Abstract
Summary
Anesthesia is a kind of narcotic drug used in anesthesiology, which can temporarily and reversibly make people lose consciousness. Anesthetics fall into two broad categories: general anesthetics cause a reversible loss of consciousness; local anesthetics cause a reversible loss of sensation in a limited area of the body while maintaining consciousness. Combinations of narcotic drugs are sometimes used to enhance the effects of treatment, and side effects may also increase. Narcotic drugs, also known as poisonous anesthetics, first generally refer to drugs that can cause humans to fall into sleep, coma or unconsciousness. In the United States, it is used to refer to opioid drugs such as opium, heroin, morphine, pethidine, or derivatives of opioids.
The global market for Medical Anesthetics was estimated to be worth US$ 20060 million in 2023 and is forecast to a readjusted size of US$ 34740 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030
North American market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Medical Anesthetics include Renfu Medicine, Nhwa Pharmaceuticals, Hengrui Medicine, Yangzijiang Pharmaceutical, AbbVie Inc., AstraZeneca Plc, Avet Pharmaceuticals Inc., B Braun Melsungen AG and Baxter International Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Anesthetics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Anesthetics by region & country, by Type, and by Application.
The Medical Anesthetics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Anesthetics.
Market Segmentation
By Company
Renfu Medicine
Nhwa Pharmaceuticals
Hengrui Medicine
Yangzijiang Pharmaceutical
AbbVie Inc.
AstraZeneca Plc
Avet Pharmaceuticals Inc.
B Braun Melsungen AG
Baxter International Inc.
Eisai
Fresenius SE and Co. KGaA
Glenmark
Hikma
Maruishi Pharmaceutical Co. Ltd.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Piramal
Septodont Holding
Segment by Type:
General Anesthetic
Local Anesthetic
Anesthesia Aids
Segment by Application
General Surgery
Plastic Surgery
Cosmetic Surgery
Dental Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Anesthetics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Anesthetics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Medical Anesthetics was estimated to be worth US$ 20060 million in 2023 and is forecast to a readjusted size of US$ 34740 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030
North American market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Medical Anesthetics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Medical Anesthetics include Renfu Medicine, Nhwa Pharmaceuticals, Hengrui Medicine, Yangzijiang Pharmaceutical, AbbVie Inc., AstraZeneca Plc, Avet Pharmaceuticals Inc., B Braun Melsungen AG and Baxter International Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Anesthetics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Anesthetics by region & country, by Type, and by Application.
The Medical Anesthetics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Anesthetics.
Market Segmentation
By Company
Renfu Medicine
Nhwa Pharmaceuticals
Hengrui Medicine
Yangzijiang Pharmaceutical
AbbVie Inc.
AstraZeneca Plc
Avet Pharmaceuticals Inc.
B Braun Melsungen AG
Baxter International Inc.
Eisai
Fresenius SE and Co. KGaA
Glenmark
Hikma
Maruishi Pharmaceutical Co. Ltd.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Piramal
Septodont Holding
Segment by Type:
General Anesthetic
Local Anesthetic
Anesthesia Aids
Segment by Application
General Surgery
Plastic Surgery
Cosmetic Surgery
Dental Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Anesthetics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Anesthetics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Medical Anesthetics Product Introduction
1.2 Global Medical Anesthetics Market Size Forecast
1.3 Medical Anesthetics Market Trends & Drivers
1.3.1 Medical Anesthetics Industry Trends
1.3.2 Medical Anesthetics Market Drivers & Opportunity
1.3.3 Medical Anesthetics Market Challenges
1.3.4 Medical Anesthetics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Anesthetics Players Revenue Ranking (2023)
2.2 Global Medical Anesthetics Revenue by Company (2019-2024)
2.3 Key Companies Medical Anesthetics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Anesthetics Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Anesthetics
2.6 Medical Anesthetics Market Competitive Analysis
2.6.1 Medical Anesthetics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical Anesthetics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Anesthetics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 General Anesthetic
3.1.2 Local Anesthetic
3.1.3 Anesthesia Aids
3.2 Global Medical Anesthetics Sales Value by Type
3.2.1 Global Medical Anesthetics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Anesthetics Sales Value, by Type (2019-2030)
3.2.3 Global Medical Anesthetics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 General Surgery
4.1.2 Plastic Surgery
4.1.3 Cosmetic Surgery
4.1.4 Dental Surgery
4.1.5 Others
4.2 Global Medical Anesthetics Sales Value by Application
4.2.1 Global Medical Anesthetics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Anesthetics Sales Value, by Application (2019-2030)
4.2.3 Global Medical Anesthetics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical Anesthetics Sales Value by Region
5.1.1 Global Medical Anesthetics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Anesthetics Sales Value by Region (2019-2024)
5.1.3 Global Medical Anesthetics Sales Value by Region (2025-2030)
5.1.4 Global Medical Anesthetics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical Anesthetics Sales Value, 2019-2030
5.2.2 North America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical Anesthetics Sales Value, 2019-2030
5.3.2 Europe Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Anesthetics Sales Value, 2019-2030
5.4.2 Asia Pacific Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical Anesthetics Sales Value, 2019-2030
5.5.2 South America Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Anesthetics Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical Anesthetics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Anesthetics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Anesthetics Sales Value
6.3 United States
6.3.1 United States Medical Anesthetics Sales Value, 2019-2030
6.3.2 United States Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Anesthetics Sales Value, 2019-2030
6.4.2 Europe Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Anesthetics Sales Value, 2019-2030
6.5.2 China Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Anesthetics Sales Value, 2019-2030
6.6.2 Japan Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Anesthetics Sales Value, 2019-2030
6.7.2 South Korea Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Anesthetics Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Anesthetics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Anesthetics Sales Value, 2019-2030
6.9.2 India Medical Anesthetics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Anesthetics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Renfu Medicine
7.1.1 Renfu Medicine Profile
7.1.2 Renfu Medicine Main Business
7.1.3 Renfu Medicine Medical Anesthetics Products, Services and Solutions
7.1.4 Renfu Medicine Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.1.5 Renfu Medicine Recent Developments
7.2 Nhwa Pharmaceuticals
7.2.1 Nhwa Pharmaceuticals Profile
7.2.2 Nhwa Pharmaceuticals Main Business
7.2.3 Nhwa Pharmaceuticals Medical Anesthetics Products, Services and Solutions
7.2.4 Nhwa Pharmaceuticals Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.2.5 Nhwa Pharmaceuticals Recent Developments
7.3 Hengrui Medicine
7.3.1 Hengrui Medicine Profile
7.3.2 Hengrui Medicine Main Business
7.3.3 Hengrui Medicine Medical Anesthetics Products, Services and Solutions
7.3.4 Hengrui Medicine Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.3.5 Yangzijiang Pharmaceutical Recent Developments
7.4 Yangzijiang Pharmaceutical
7.4.1 Yangzijiang Pharmaceutical Profile
7.4.2 Yangzijiang Pharmaceutical Main Business
7.4.3 Yangzijiang Pharmaceutical Medical Anesthetics Products, Services and Solutions
7.4.4 Yangzijiang Pharmaceutical Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.4.5 Yangzijiang Pharmaceutical Recent Developments
7.5 AbbVie Inc.
7.5.1 AbbVie Inc. Profile
7.5.2 AbbVie Inc. Main Business
7.5.3 AbbVie Inc. Medical Anesthetics Products, Services and Solutions
7.5.4 AbbVie Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.5.5 AbbVie Inc. Recent Developments
7.6 AstraZeneca Plc
7.6.1 AstraZeneca Plc Profile
7.6.2 AstraZeneca Plc Main Business
7.6.3 AstraZeneca Plc Medical Anesthetics Products, Services and Solutions
7.6.4 AstraZeneca Plc Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.6.5 AstraZeneca Plc Recent Developments
7.7 Avet Pharmaceuticals Inc.
7.7.1 Avet Pharmaceuticals Inc. Profile
7.7.2 Avet Pharmaceuticals Inc. Main Business
7.7.3 Avet Pharmaceuticals Inc. Medical Anesthetics Products, Services and Solutions
7.7.4 Avet Pharmaceuticals Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.7.5 Avet Pharmaceuticals Inc. Recent Developments
7.8 B Braun Melsungen AG
7.8.1 B Braun Melsungen AG Profile
7.8.2 B Braun Melsungen AG Main Business
7.8.3 B Braun Melsungen AG Medical Anesthetics Products, Services and Solutions
7.8.4 B Braun Melsungen AG Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.8.5 B Braun Melsungen AG Recent Developments
7.9 Baxter International Inc.
7.9.1 Baxter International Inc. Profile
7.9.2 Baxter International Inc. Main Business
7.9.3 Baxter International Inc. Medical Anesthetics Products, Services and Solutions
7.9.4 Baxter International Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.9.5 Baxter International Inc. Recent Developments
7.10 Eisai
7.10.1 Eisai Profile
7.10.2 Eisai Main Business
7.10.3 Eisai Medical Anesthetics Products, Services and Solutions
7.10.4 Eisai Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.10.5 Eisai Recent Developments
7.11 Fresenius SE and Co. KGaA
7.11.1 Fresenius SE and Co. KGaA Profile
7.11.2 Fresenius SE and Co. KGaA Main Business
7.11.3 Fresenius SE and Co. KGaA Medical Anesthetics Products, Services and Solutions
7.11.4 Fresenius SE and Co. KGaA Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.11.5 Fresenius SE and Co. KGaA Recent Developments
7.12 Glenmark
7.12.1 Glenmark Profile
7.12.2 Glenmark Main Business
7.12.3 Glenmark Medical Anesthetics Products, Services and Solutions
7.12.4 Glenmark Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.12.5 Glenmark Recent Developments
7.13 Hikma
7.13.1 Hikma Profile
7.13.2 Hikma Main Business
7.13.3 Hikma Medical Anesthetics Products, Services and Solutions
7.13.4 Hikma Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.13.5 Hikma Recent Developments
7.14 Maruishi Pharmaceutical Co. Ltd.
7.14.1 Maruishi Pharmaceutical Co. Ltd. Profile
7.14.2 Maruishi Pharmaceutical Co. Ltd. Main Business
7.14.3 Maruishi Pharmaceutical Co. Ltd. Medical Anesthetics Products, Services and Solutions
7.14.4 Maruishi Pharmaceutical Co. Ltd. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.14.5 Maruishi Pharmaceutical Co. Ltd. Recent Developments
7.15 Merck and Co. Inc.
7.15.1 Merck and Co. Inc. Profile
7.15.2 Merck and Co. Inc. Main Business
7.15.3 Merck and Co. Inc. Medical Anesthetics Products, Services and Solutions
7.15.4 Merck and Co. Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.15.5 Merck and Co. Inc. Recent Developments
7.16 Novartis AG
7.16.1 Novartis AG Profile
7.16.2 Novartis AG Main Business
7.16.3 Novartis AG Medical Anesthetics Products, Services and Solutions
7.16.4 Novartis AG Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.16.5 Novartis AG Recent Developments
7.17 Pfizer Inc.
7.17.1 Pfizer Inc. Profile
7.17.2 Pfizer Inc. Main Business
7.17.3 Pfizer Inc. Medical Anesthetics Products, Services and Solutions
7.17.4 Pfizer Inc. Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.17.5 Pfizer Inc. Recent Developments
7.18 Piramal
7.18.1 Piramal Profile
7.18.2 Piramal Main Business
7.18.3 Piramal Medical Anesthetics Products, Services and Solutions
7.18.4 Piramal Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.18.5 Piramal Recent Developments
7.19 Septodont Holding
7.19.1 Septodont Holding Profile
7.19.2 Septodont Holding Main Business
7.19.3 Septodont Holding Medical Anesthetics Products, Services and Solutions
7.19.4 Septodont Holding Medical Anesthetics Revenue (US$ Million) & (2019-2024)
7.19.5 Septodont Holding Recent Developments
8 Industry Chain Analysis
8.1 Medical Anesthetics Industrial Chain
8.2 Medical Anesthetics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Anesthetics Sales Model
8.5.2 Sales Channel
8.5.3 Medical Anesthetics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer